COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 849: Articles 8481-8490  | Next

Hierarchical Computational Modeling and Dynamic Network Analysis of Allosteric Regulation in the SARS-CoV-2 Spike Omicron Trimer Structures: Omicron Mutations Cooperate to Allosterically Control Balance of Protein Stability and Conformational Adaptability
Verkhivker, G. M., Agajanian, S., Kassab, R., Krishnan, K.
10.1101/2022.04.11.487920 — Posted: 2022-04-12
A high potent synthetic nanobody with broad-spectrum activity neutralizes SARS-Cov-2 virus and Omicron variant through a unique binding mode
Huang, H., Li, S., Tao, Y., Xing, D., Xiong, H., Zhang, J., Li, L., Yang, X., Jiang, D., Luan, L., Lin, Y., Liu, X., Zheng, Q., Zhao, D., Xia, N., Liu, L.
10.1101/2022.04.11.487660 — Posted: 2022-04-12
An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity
Schmidt, N. M., Wing, P. A., Peters, R., Brown, R., Wang, H., Swadling, L., Newman, J., Thakur, N., Shionoya, K., Morgan, S. B., Hinks, T. S., Watashi, K., Bailey, D., Hansen, S. B., Maini, M. K., McKeating, J. A.
10.1101/2022.04.12.487988 — Posted: 2022-04-12
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Chen, M., Pekosz, A., Villano, J., Shen, W., Zhou, R., Kulaga, H., Li, Z., Beck, S. E., Witwer, K. W., Mankowski, J., Ramanathan, M., Rowan, N., Lane, A.
10.1101/2022.04.12.487379 — Posted: 2022-04-12
From elimination to suppression: genomic epidemiology of a large Delta SARS-CoV-2 outbreak in Aotearoa New Zealand
Jelley, L., Douglas, J., Ren, X., Winter, D., McNeill, A., Huang, S., French, N., Welch, D., Hadfield, J., de Ligt, J., Geoghegan, J. L.
10.1101/2022.04.04.22273376 — Posted: 2022-04-12
Receptor binding domain of SARS-CoV-2 is a functional αv-integrin agonist
Norris, E. G., Pan, X. S., Hocking, D. C.
10.1101/2022.04.11.487882 — Posted: 2022-04-11
Disrupting ACE2 Dimerization Mitigates the Infection by SARS-COV-2
Zhu, J., Su, Y., Tang, Y.
10.1101/2022.04.09.487739 — Posted: 2022-04-11
Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants
Wang, Q., Ye, S.-B., Zhou, Z.-J., Li, J.-Y., Lv, J.-Z., Hu, B., Yuan, S., Qiu, Y., Ge, X.-Y.
10.1101/2022.04.11.487828 — Posted: 2022-04-11
SARS-ANI: A Global Open Access Dataset of Reported SARS-CoV-2 Events in Animals
Nerpel, A., Yang, L., Sorger, J., Kaesbohrer, A., Walzer, C., Desvars-Larrive, A.
10.1101/2022.04.11.487836 — Posted: 2022-04-11
Candidate genes associated with neurological manifestations of COVID-19: Meta-analysis using multiple computational approaches
Hazra, S., Ghosh Chaudhuri, A., Tiwary, B. K., Chakrabarti, N.
10.1101/2022.04.10.487761 — Posted: 2022-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).